Medicine:Stemirna COVID-19 vaccine
From HandWiki
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | mrna |
| Clinical data | |
| Routes of administration | Intramuscular |
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics.[1][2]
References
- ↑ "Randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of mRNACOVID-19 vaccine in healthy susceptible populations aged 18 years and older people". http://www.chictr.org.cn/showprojen.aspx?proj=126046.
- ↑ Clinical trial number NCT05144139 for "A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above" at ClinicalTrials.gov
 |
